Skip to main content
 
Previous Pause Next

What if…

  • Patients could benefit from a medicine prior to marketing approval or commercial availability?
  • A patient lives in a country where a much needed medicine may never be available?
  • A clinical trial participant needs access to the therapy after they exit the trial?
  • There is a drug shortage or discontinuation?

Idis has the answer.

  • Fully compliant solutions that enable access to medicines prior to approval and launch.
  • Access following clinical trials and the transition of patients to commercial supply.
  • Options when there is a discontinuation or drug shortage.
For patients: Access to medicines for unmet medical needs
For physicians: Timely access to medicines for your patients
For pharmacists: Access to therapeutic options when availability is a challenge
For pharmaceutical and biotechnology companies: Meeting global patient demand
Patients
Physicians
Pharmacists
Companies

INSIGHTS on Access

Sign up for our newsletter “Insights on Access” and get all the latest and greatest information on Managed Access Programs and more…

Sign Up

Recent News

Idis welcomes two industry veterans to the company’s leadership team: Sue Barrowcliffe, Global Director of Regulatory and Medical Strategy, and Jeff Oliva, Senior Vice President of Global Business Development.

Read more

View All

Webinars

Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch

View webinar

Managed Access Overview

A narrated tour of Managed Access Programs (MAP)

View Animation

A background on MAP

Read PDF

Take Survey

Survey

Tell us what you think of the Idis website!

Take survey